Skip to main content
Erschienen in: The journal of nutrition, health & aging 6/2016

18.12.2015

Inappropriate use of proton pump inhibitors in elderly patients discharged from acute care hospitals

verfasst von: R. Schepisi, Sergio Fusco, F. Sganga, B. Falcone, D. L. Vetrano, A. Abbatecola, F. Corica, M. Maggio, C. Ruggiero, P. Fabbietti, A. Corsonello, G. Onder, F. Lattanzio

Erschienen in: The journal of nutrition, health & aging | Ausgabe 6/2016

Einloggen, um Zugang zu erhalten

Abstract

Background

Proton-pump inhibitors (PPI) are extensively prescribed in older patients. However, little information is available on factors associated to PPI prescribing patterns among older patients discharged from hospital.

Objective

To evaluate the appropriateness and clinical correlates of PPI prescription at discharge in a population of 1081 older patients discharged from acute care Italian hospitals.

Design

We used data from the CRiteria to Assess Appropriate Medication Use among Elderly Complex Patients (CRIME) study, a multicenter observational study. The appropriateness of PPI prescriptions was defined according to the Italian Medicines Agency (AIFA) rules. Correlates of overprescribing (i.e prescribing without recognized AIFA indications) and underprescribing (i.e. not prescribing despite the presence of recognized AIFA indications) were investigated by logistic regression analysis.

Results

Overprescribing was observed in 30% of patients receiving PPIs at discharge. Underprescribing was observed in 11% of patients not receiving PPIs at discharge. Overprescribing of PPIs at discharge was negatively associated with age (OR=0.88, 95%CI=0.85-0.91), depression (OR=0.58, 95%CI=0.35-0.96), use of aspirin (OR=0.03, 95%CI=0.02-0.06) and systemic corticosteroids (OR=0.02, 95%CI=0.01-0.04). The negative association with number of medications (OR=0.95, 95%CI=0.88-1.03) and overall comorbidities (OR=0.92, 95%CI=0.83-1.02) was nearly significant. Conversely, older age (OR=1.09, 95%CI=1.04-1.14), use of aspirin (OR=24.0, 95%CI=11.5-49.8) and systemic corticosteroids (OR=19.3, 95%CI=11.5-49.8) and overall comorbidities (OR=1.22, 95%CI=1.04-1.42) were independent correlates of underprescribing.

Conclusion

Overprescribing of PPIs is more frequent in younger patients with lower burden of depression, whilst underprescribing is characterized by older age and greater burden of comorbidity and polypharmacy. Hospitalization should be considered as a clue to identify inappropriate use of PPIs and improve appropriateness of prescribing.
Literatur
1.
Zurück zum Zitat McCarthy DM. Adverse effects of proton pump inhibitor drugs: clues and conclusions. Curr Opin Gastroenterol. 2010 Nov;26:624–31.CrossRefPubMed McCarthy DM. Adverse effects of proton pump inhibitor drugs: clues and conclusions. Curr Opin Gastroenterol. 2010 Nov;26:624–31.CrossRefPubMed
2.
Zurück zum Zitat Bhatt DL, Scheiman J, Abraham NS, Antman EM, Chan FK, Furberg CD, Johnson DA, Mahaffey KW, Quigley EM. ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents. Circulation. 2008 Oct 28;118:1894–909.CrossRefPubMed Bhatt DL, Scheiman J, Abraham NS, Antman EM, Chan FK, Furberg CD, Johnson DA, Mahaffey KW, Quigley EM. ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents. Circulation. 2008 Oct 28;118:1894–909.CrossRefPubMed
3.
Zurück zum Zitat Pilotto A, Franceschi M, Leandro G, Scarcelli C, D’Ambrosio LP, Seripa D, Perri F, Niro V, Paris F, et al. Clinical features of reflux esophagitis in older people: a study of 840 consecutive patients. J Am Geriatr Soc. 2006 Oct;54:1537–42.CrossRefPubMed Pilotto A, Franceschi M, Leandro G, Scarcelli C, D’Ambrosio LP, Seripa D, Perri F, Niro V, Paris F, et al. Clinical features of reflux esophagitis in older people: a study of 840 consecutive patients. J Am Geriatr Soc. 2006 Oct;54:1537–42.CrossRefPubMed
4.
Zurück zum Zitat IMS Health Report: IMS National Prescription Audit. New Jersey: IMS; 2011. Available at http://www.imshealth.com/ims/Global/Content/Insights/IMS%20 Institute%20for%20Healthcare%20Informatics/IHII_Medicines_in_U.S_ Report_2011.pdf Last accessed June 13, 2013 IMS Health Report: IMS National Prescription Audit. New Jersey: IMS; 2011. Available at http://​www.​imshealth.​com/​ims/​Global/​Content/​Insights/​IMS%20 Institute%20for%20Healthcare%20Informatics/IHII_Medicines_in_U.S_ Report_2011.pdf Last accessed June 13, 2013
5.
Zurück zum Zitat L’uso dei farmaci in Italia-Rapporto OsMed. December 2012. Available at http://www.agenziafarmaco.gov.it/it/content/luso-dei-farmaci-italia-rapporto-osmedgennaio-settembre-2012. Last accessed June 13, 2013 L’uso dei farmaci in Italia-Rapporto OsMed. December 2012. Available at http://​www.​agenziafarmaco.​gov.​it/​it/​content/​luso-dei-farmaci-italia-rapporto-osmedgennaio-settembre-2012.​ Last accessed June 13, 2013
6.
Zurück zum Zitat Bell JS, Strandberg TE, Teramura-Gronblad M, Laurila JV, Tilvis RS, Pitkala KH. Use of proton pump inhibitors and mortality among institutionalized older people. Arch Intern Med. 2010 Sep 27;170:1604–5.PubMed Bell JS, Strandberg TE, Teramura-Gronblad M, Laurila JV, Tilvis RS, Pitkala KH. Use of proton pump inhibitors and mortality among institutionalized older people. Arch Intern Med. 2010 Sep 27;170:1604–5.PubMed
7.
Zurück zum Zitat Teramura-Gronblad M, Bell JS, Poysti MM, Strandberg TE, Laurila JV, Tilvis RS, Soini H, Pitkala KH. Risk of death associated with use of PPIs in three cohorts of institutionalized older people in Finland. J Am Med Dir Assoc. 2012 Jun;13:488e9-13.CrossRefPubMed Teramura-Gronblad M, Bell JS, Poysti MM, Strandberg TE, Laurila JV, Tilvis RS, Soini H, Pitkala KH. Risk of death associated with use of PPIs in three cohorts of institutionalized older people in Finland. J Am Med Dir Assoc. 2012 Jun;13:488e9-13.CrossRefPubMed
8.
Zurück zum Zitat Maggio M, Corsonello A, Ceda GP, Cattabiani C, Lauretani F, Butto V, Ferrucci L, Bandinelli S, Abbatecola AM, et al. Proton pump inhibitors and risk of 1-year mortality and rehospitalization in older patients discharged from acute care hospitals. JAMA Intern Med. 2013 Apr 8;173:518–23.CrossRefPubMed Maggio M, Corsonello A, Ceda GP, Cattabiani C, Lauretani F, Butto V, Ferrucci L, Bandinelli S, Abbatecola AM, et al. Proton pump inhibitors and risk of 1-year mortality and rehospitalization in older patients discharged from acute care hospitals. JAMA Intern Med. 2013 Apr 8;173:518–23.CrossRefPubMed
9.
Zurück zum Zitat Corsonello A, Maggio M, Fusco S, Adamo B, Amantea D, Pedone C, Garasto S, Ceda GP, Corica F, et al. Proton pump inhibitors and functional decline in older adults discharged from acute care hospitals. J Am Geriatr Soc. 2014 Jun;62:1110–5.CrossRefPubMed Corsonello A, Maggio M, Fusco S, Adamo B, Amantea D, Pedone C, Garasto S, Ceda GP, Corica F, et al. Proton pump inhibitors and functional decline in older adults discharged from acute care hospitals. J Am Geriatr Soc. 2014 Jun;62:1110–5.CrossRefPubMed
10.
Zurück zum Zitat Linsky A, Gupta K, Lawler EV, Fonda JR, Hermos JA. Proton pump inhibitors and risk for recurrent Clostridium difficile infection. Arch Intern Med. 2010 May 10;170:772–8.CrossRefPubMed Linsky A, Gupta K, Lawler EV, Fonda JR, Hermos JA. Proton pump inhibitors and risk for recurrent Clostridium difficile infection. Arch Intern Med. 2010 May 10;170:772–8.CrossRefPubMed
11.
Zurück zum Zitat Yu EW, Bauer SS, Bain PA et al. Proton-pump inhibitor and risk of fractures: a metaanalysis of 11 international studies. Am J Med 2011; 124: 519–526CrossRefPubMedPubMedCentral Yu EW, Bauer SS, Bain PA et al. Proton-pump inhibitor and risk of fractures: a metaanalysis of 11 international studies. Am J Med 2011; 124: 519–526CrossRefPubMedPubMedCentral
12.
Zurück zum Zitat Charlot M, Grove EL, Hansen PR, Olesen JB, Ahlehoff O, Selmer C, Lindhardsen J, Madsen JK, Kober L, et al. Proton pump inhibitor use and risk of adverse cardiovascular events in aspirin treated patients with first time myocardial infarction: nationwide propensity score matched study. BMJ. 2011;342:d2690.CrossRefPubMedPubMedCentral Charlot M, Grove EL, Hansen PR, Olesen JB, Ahlehoff O, Selmer C, Lindhardsen J, Madsen JK, Kober L, et al. Proton pump inhibitor use and risk of adverse cardiovascular events in aspirin treated patients with first time myocardial infarction: nationwide propensity score matched study. BMJ. 2011;342:d2690.CrossRefPubMedPubMedCentral
13.
Zurück zum Zitat Shi S, Klotz U. Proton pump inhibitors: an update of their clinical use and pharmacokinetics. Eur J Clin Pharmacol. 2008 Oct;64:935–51.CrossRefPubMed Shi S, Klotz U. Proton pump inhibitors: an update of their clinical use and pharmacokinetics. Eur J Clin Pharmacol. 2008 Oct;64:935–51.CrossRefPubMed
14.
Zurück zum Zitat Patterson Burdsall D, Flores HC, Krueger J, Garretson S, Gorbien MJ, Iacch A, Dobbs V, Homa T. Use of proton pump inhibitors with lack of diagnostic indications in 22 Midwestern US skilled nursing facilities. J Am Med Dir Assoc. 2013 Jun;14:429–32.CrossRefPubMed Patterson Burdsall D, Flores HC, Krueger J, Garretson S, Gorbien MJ, Iacch A, Dobbs V, Homa T. Use of proton pump inhibitors with lack of diagnostic indications in 22 Midwestern US skilled nursing facilities. J Am Med Dir Assoc. 2013 Jun;14:429–32.CrossRefPubMed
15.
Zurück zum Zitat Godman B, Wettermark B, van Woerkom M, Fraeyman J, Alvarez-Madrazo S, Berg C, Bishop I, Bucsics A, Campbell S, et al. Multiple policies to enhance prescribing efficiency for established medicines in Europe with a particular focus on demandside measures: findings and future implications. Front Pharmacol. 2014;5:106.PubMedPubMedCentral Godman B, Wettermark B, van Woerkom M, Fraeyman J, Alvarez-Madrazo S, Berg C, Bishop I, Bucsics A, Campbell S, et al. Multiple policies to enhance prescribing efficiency for established medicines in Europe with a particular focus on demandside measures: findings and future implications. Front Pharmacol. 2014;5:106.PubMedPubMedCentral
16.
Zurück zum Zitat Parente F, Cucino C, Gallus S, Bargiggia S, Greco S, Pastore L, Bianchi Porro G. Hospital use of acid-suppressive medications and its fall-out on prescribing in general practice: a 1-month survey. Aliment Pharmacol Ther. 2003 Jun 15;17:1503–6.CrossRefPubMed Parente F, Cucino C, Gallus S, Bargiggia S, Greco S, Pastore L, Bianchi Porro G. Hospital use of acid-suppressive medications and its fall-out on prescribing in general practice: a 1-month survey. Aliment Pharmacol Ther. 2003 Jun 15;17:1503–6.CrossRefPubMed
17.
Zurück zum Zitat Jarchow-Macdonald AA, Mangoni AA. Prescribing patterns of proton pump inhibitors in older hospitalized patients in a Scottish health board. Geriatr Gerontol Int. 2013 Oct;13:1002–9.CrossRefPubMed Jarchow-Macdonald AA, Mangoni AA. Prescribing patterns of proton pump inhibitors in older hospitalized patients in a Scottish health board. Geriatr Gerontol Int. 2013 Oct;13:1002–9.CrossRefPubMed
18.
Zurück zum Zitat Tosato M, Settanni S, Antocicco M, Battaglia M, Corsonello A, Ruggiero C, Volpato S, Fabbietti P, Lattanzio F, et al. Pattern of medication use among older inpatients in seven hospitals in Italy: results from the CRiteria to assess Appropriate Medication use among Elderly complex patients (CRIME) project. Curr Drug Saf. 2013 Apr;8:98–103.CrossRefPubMed Tosato M, Settanni S, Antocicco M, Battaglia M, Corsonello A, Ruggiero C, Volpato S, Fabbietti P, Lattanzio F, et al. Pattern of medication use among older inpatients in seven hospitals in Italy: results from the CRiteria to assess Appropriate Medication use among Elderly complex patients (CRIME) project. Curr Drug Saf. 2013 Apr;8:98–103.CrossRefPubMed
19.
Zurück zum Zitat Pahor M, Chrischilles EA, Guralnik JM, Brown SL, Wallace RB, Carbonin P. Drug data coding and analysis in epidemiologic studies. Eur J Epidemiol. 1994 Aug;10:405–11.CrossRefPubMed Pahor M, Chrischilles EA, Guralnik JM, Brown SL, Wallace RB, Carbonin P. Drug data coding and analysis in epidemiologic studies. Eur J Epidemiol. 1994 Aug;10:405–11.CrossRefPubMed
20.
Zurück zum Zitat http://www.agenziafarmaco.gov.it/sites/default/files/Note_AIFA_testo_06-07.pdf http://www.agenziafarmaco.gov.it/sites/default/files/Note_AIFA_testo_06-07.pdf
21.
Zurück zum Zitat Folstein MF, Folstein SE, McHugh PR. «Mini-mental state». A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975 Nov;12:189–98.CrossRefPubMed Folstein MF, Folstein SE, McHugh PR. «Mini-mental state». A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975 Nov;12:189–98.CrossRefPubMed
22.
Zurück zum Zitat Lesher EL, Berryhill JS. Validation of the Geriatric Depression Scale—Short Form among inpatients. J Clin Psychol. 1994 Mar;50:256–60.CrossRefPubMed Lesher EL, Berryhill JS. Validation of the Geriatric Depression Scale—Short Form among inpatients. J Clin Psychol. 1994 Mar;50:256–60.CrossRefPubMed
24.
Zurück zum Zitat Lai KC, Lam SK, Chu KM, Wong BC, Hui WM, Hu WH, Lau GK, Wong WM, Yuen MF, et al. Lansoprazole for the prevention of recurrences of ulcer complications from long-term low-dose aspirin use. N Engl J Med. 2002 Jun 27;346:2033–8.CrossRefPubMed Lai KC, Lam SK, Chu KM, Wong BC, Hui WM, Hu WH, Lau GK, Wong WM, Yuen MF, et al. Lansoprazole for the prevention of recurrences of ulcer complications from long-term low-dose aspirin use. N Engl J Med. 2002 Jun 27;346:2033–8.CrossRefPubMed
25.
Zurück zum Zitat Gulmez SE, Holm A, Frederiksen H, Jensen TG, Pedersen C, Hallas J. Use of proton pump inhibitors and the risk of community-acquired pneumonia: a population-based case-control study. Arch Intern Med. 2007 May 14;167:950–5.CrossRefPubMed Gulmez SE, Holm A, Frederiksen H, Jensen TG, Pedersen C, Hallas J. Use of proton pump inhibitors and the risk of community-acquired pneumonia: a population-based case-control study. Arch Intern Med. 2007 May 14;167:950–5.CrossRefPubMed
26.
Zurück zum Zitat Yang YX, Lewis JD, Epstein S, Metz DC. Long-term proton pump inhibitor therapy and risk of hip fracture. JAMA. 2006 Dec 27;296:2947–53.CrossRefPubMed Yang YX, Lewis JD, Epstein S, Metz DC. Long-term proton pump inhibitor therapy and risk of hip fracture. JAMA. 2006 Dec 27;296:2947–53.CrossRefPubMed
27.
Zurück zum Zitat Nardino RJ, Vender RJ, Herbert PN. Overuse of acid-suppressive therapy in hospitalized patients. Am J Gastroenterol. 2000 Nov;95:3118–22.CrossRefPubMed Nardino RJ, Vender RJ, Herbert PN. Overuse of acid-suppressive therapy in hospitalized patients. Am J Gastroenterol. 2000 Nov;95:3118–22.CrossRefPubMed
28.
Zurück zum Zitat Gullotta R, Ferraris L, Cortelezzi C, Minoli G, Prada A, Comin U, Rocca F, Ferrara A, Curzio M. Are we correctly using the inhibitors of gastric acid secretion and cytoprotective drugs? Results of a multicentre study. Ital J Gastroenterol Hepatol. 1997 Aug;29:325–9.PubMed Gullotta R, Ferraris L, Cortelezzi C, Minoli G, Prada A, Comin U, Rocca F, Ferrara A, Curzio M. Are we correctly using the inhibitors of gastric acid secretion and cytoprotective drugs? Results of a multicentre study. Ital J Gastroenterol Hepatol. 1997 Aug;29:325–9.PubMed
29.
Zurück zum Zitat Leri F, Ayzenberg M, Voyce SJ, Klein A, Hartz L, Smego RA, Jr. Four-year trends of inappropriate proton pump inhibitor use after hospital discharge. South Med J. 2013 Apr;106:270–3.CrossRefPubMed Leri F, Ayzenberg M, Voyce SJ, Klein A, Hartz L, Smego RA, Jr. Four-year trends of inappropriate proton pump inhibitor use after hospital discharge. South Med J. 2013 Apr;106:270–3.CrossRefPubMed
30.
Zurück zum Zitat Tett SE, Sketris I, Cooke C, Veldhuyzen van Zanten S, BarozziN. Differences in utilisation of gastroprotective drugs between 2001 and 2005 in Australia and Nova Scotia, Canada. Pharmacoepidemiol Drug Saf 2013; 22: 735–743CrossRefPubMed Tett SE, Sketris I, Cooke C, Veldhuyzen van Zanten S, BarozziN. Differences in utilisation of gastroprotective drugs between 2001 and 2005 in Australia and Nova Scotia, Canada. Pharmacoepidemiol Drug Saf 2013; 22: 735–743CrossRefPubMed
31.
Zurück zum Zitat Valkhoff VE, van Soest EM, Sturkenboom MC, Kuipers EJ. Time-trends in gastroprotection with nonsteroidal anti-inflammatory drugs (NSAIDs). Aliment Pharmacol Ther. 2010 Jun;31:1218–28.CrossRefPubMed Valkhoff VE, van Soest EM, Sturkenboom MC, Kuipers EJ. Time-trends in gastroprotection with nonsteroidal anti-inflammatory drugs (NSAIDs). Aliment Pharmacol Ther. 2010 Jun;31:1218–28.CrossRefPubMed
32.
Zurück zum Zitat Ahrens D, Behrens G, Himmel W, Kochen MM, Chenot JF. Appropriateness of proton pump inhibitor recommendations at hospital discharge and continuation in primary care. Int J Clin Pract. 2012 Aug;66:767–73.CrossRefPubMed Ahrens D, Behrens G, Himmel W, Kochen MM, Chenot JF. Appropriateness of proton pump inhibitor recommendations at hospital discharge and continuation in primary care. Int J Clin Pract. 2012 Aug;66:767–73.CrossRefPubMed
33.
Zurück zum Zitat Sheikh-Taha M, Alaeddine S, Nassif J. Use of acid suppressive therapy in hospitalized non-critically ill patients. World J Gastrointest Pharmacol Ther. 2012 Dec 6;3:93–6.PubMedPubMedCentral Sheikh-Taha M, Alaeddine S, Nassif J. Use of acid suppressive therapy in hospitalized non-critically ill patients. World J Gastrointest Pharmacol Ther. 2012 Dec 6;3:93–6.PubMedPubMedCentral
34.
Zurück zum Zitat Sganga F, Vetrano DL, Volpato S, Cherubini A, Ruggiero C, Corsonello A, Fabbietti P, Lattanzio F, Bernabei R, Onder G. Physical performance measures and polypharmacy among hospitalized older adults: results from the CRIME study. J Nutr Health Aging. 2014;18:616–21.CrossRefPubMed Sganga F, Vetrano DL, Volpato S, Cherubini A, Ruggiero C, Corsonello A, Fabbietti P, Lattanzio F, Bernabei R, Onder G. Physical performance measures and polypharmacy among hospitalized older adults: results from the CRIME study. J Nutr Health Aging. 2014;18:616–21.CrossRefPubMed
35.
Zurück zum Zitat Charlot M, Ahlehoff O, Norgaard ML, Jorgensen CH, Sorensen R, Abildstrom SZ, Hansen PR, Madsen JK, Kober L, et al. Proton-pump inhibitors are associated with increased cardiovascular risk independent of clopidogrel use: a nationwide cohort study. Ann Intern Med. 2010 Sep 21;153:378–86.CrossRefPubMed Charlot M, Ahlehoff O, Norgaard ML, Jorgensen CH, Sorensen R, Abildstrom SZ, Hansen PR, Madsen JK, Kober L, et al. Proton-pump inhibitors are associated with increased cardiovascular risk independent of clopidogrel use: a nationwide cohort study. Ann Intern Med. 2010 Sep 21;153:378–86.CrossRefPubMed
36.
Zurück zum Zitat Ito T, Jensen RT. Association of long-term proton pump inhibitor therapy with bone fractures and effects on absorption of calcium, vitamin B12, iron, and magnesium. Curr Gastroenterol Rep. 2010 Dec;12:448–57.CrossRefPubMedPubMedCentral Ito T, Jensen RT. Association of long-term proton pump inhibitor therapy with bone fractures and effects on absorption of calcium, vitamin B12, iron, and magnesium. Curr Gastroenterol Rep. 2010 Dec;12:448–57.CrossRefPubMedPubMedCentral
37.
Zurück zum Zitat Maggio M, Lauretani F, De Vita F, Butto V, Cattabiani C, Masoni S, Sutti E, Bondi G, Dall’aglio E, et al. Relationship between use of proton pump inhibitors and IGF system in older subjects. J Nutr Health Aging. 2014 Apr;18:420–3.CrossRefPubMed Maggio M, Lauretani F, De Vita F, Butto V, Cattabiani C, Masoni S, Sutti E, Bondi G, Dall’aglio E, et al. Relationship between use of proton pump inhibitors and IGF system in older subjects. J Nutr Health Aging. 2014 Apr;18:420–3.CrossRefPubMed
38.
Zurück zum Zitat Morneau KM, Reaves AB, Martin JB, Oliphant CS. Analysis of gastrointestinal prophylaxis in patients receiving dual antiplatelet therapy with aspirin and clopidogrel. J Manag Care Pharm. 2014 Feb;20:187–93.PubMed Morneau KM, Reaves AB, Martin JB, Oliphant CS. Analysis of gastrointestinal prophylaxis in patients receiving dual antiplatelet therapy with aspirin and clopidogrel. J Manag Care Pharm. 2014 Feb;20:187–93.PubMed
39.
Zurück zum Zitat Rostom A, Dube C, Wells G, Tugwell P, Welch V, Jolicoeur E, McGowan J. Prevention of NSAID-induced gastroduodenal ulcers. Cochrane Database Syst Rev. 2002:CD002296. Rostom A, Dube C, Wells G, Tugwell P, Welch V, Jolicoeur E, McGowan J. Prevention of NSAID-induced gastroduodenal ulcers. Cochrane Database Syst Rev. 2002:CD002296.
40.
Zurück zum Zitat Straube S, Tramer MR, Moore RA, Derry S, McQuay HJ. Mortality with upper gastrointestinal bleeding and perforation: effects of time and NSAID use. BMC Gastroenterol. 2009;9:41.CrossRefPubMedPubMedCentral Straube S, Tramer MR, Moore RA, Derry S, McQuay HJ. Mortality with upper gastrointestinal bleeding and perforation: effects of time and NSAID use. BMC Gastroenterol. 2009;9:41.CrossRefPubMedPubMedCentral
41.
Zurück zum Zitat Laharie D, Droz-Perroteau C, Benichou J, Amouretti M, Blin P, Begaud B, Guiard E, Dutoit S, Lamarque S, et al. Hospitalizations for gastrointestinal and cardiovascular events in the CADEUS cohort of traditional or Coxib NSAID users. Br J Clin Pharmacol. 2010 Mar;69:295–302.CrossRefPubMedPubMedCentral Laharie D, Droz-Perroteau C, Benichou J, Amouretti M, Blin P, Begaud B, Guiard E, Dutoit S, Lamarque S, et al. Hospitalizations for gastrointestinal and cardiovascular events in the CADEUS cohort of traditional or Coxib NSAID users. Br J Clin Pharmacol. 2010 Mar;69:295–302.CrossRefPubMedPubMedCentral
42.
Zurück zum Zitat Miyamoto M, Haruma K, Okamoto T, Higashi Y, Hidaka T, Manabe N. Continuous proton pump inhibitor treatment decreases upper gastrointestinal bleeding and related death in rural area in Japan. J Gastroenterol Hepatol. 2012 Feb;27:372–7.CrossRefPubMed Miyamoto M, Haruma K, Okamoto T, Higashi Y, Hidaka T, Manabe N. Continuous proton pump inhibitor treatment decreases upper gastrointestinal bleeding and related death in rural area in Japan. J Gastroenterol Hepatol. 2012 Feb;27:372–7.CrossRefPubMed
43.
Zurück zum Zitat McAlister FA. The end of the risk-treatment paradox? A rising tide lifts all boats. J Am Coll Cardiol. 2011 Oct 18;58:1766–7.CrossRefPubMed McAlister FA. The end of the risk-treatment paradox? A rising tide lifts all boats. J Am Coll Cardiol. 2011 Oct 18;58:1766–7.CrossRefPubMed
Metadaten
Titel
Inappropriate use of proton pump inhibitors in elderly patients discharged from acute care hospitals
verfasst von
R. Schepisi
Sergio Fusco
F. Sganga
B. Falcone
D. L. Vetrano
A. Abbatecola
F. Corica
M. Maggio
C. Ruggiero
P. Fabbietti
A. Corsonello
G. Onder
F. Lattanzio
Publikationsdatum
18.12.2015
Verlag
Springer Paris
Erschienen in
The journal of nutrition, health & aging / Ausgabe 6/2016
Print ISSN: 1279-7707
Elektronische ISSN: 1760-4788
DOI
https://doi.org/10.1007/s12603-015-0642-5

Weitere Artikel der Ausgabe 6/2016

The journal of nutrition, health & aging 6/2016 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Schadet Ärger den Gefäßen?

14.05.2024 Arteriosklerose Nachrichten

In einer Studie aus New York wirkte sich Ärger kurzfristig deutlich negativ auf die Endothelfunktion gesunder Probanden aus. Möglicherweise hat dies Einfluss auf die kardiovaskuläre Gesundheit.

Intervallfasten zur Regeneration des Herzmuskels?

14.05.2024 Herzinfarkt Nachrichten

Die Nahrungsaufnahme auf wenige Stunden am Tag zu beschränken, hat möglicherweise einen günstigen Einfluss auf die Prognose nach akutem ST-Hebungsinfarkt. Darauf deutet eine Studie an der Uniklinik in Halle an der Saale hin.

RAS-Blocker bei Hyperkaliämie möglichst nicht sofort absetzen

14.05.2024 Hyperkaliämie Nachrichten

Bei ausgeprägter Nierenfunktionsstörung steigen unter der Einnahme von Renin-Angiotensin-System(RAS)-Hemmstoffen nicht selten die Serumkaliumspiegel. Was in diesem Fall zu tun ist, erklärte Prof. Jürgen Floege beim diesjährigen Allgemeinmedizin-Update-Seminar.

Shunt-Therapie bei Herzinsuffizienz: Kein Anzug, der allen passt

13.05.2024 Chronische Herzinsuffizienz Nachrichten

Die Anlage eines interatrialen Shunts zur Reduktion des linksatrialen Drucks ist ein neuer Therapieansatz bei Herzinsuffizienz. Viele Patienten sprechen darauf an, andere jedoch nicht. 

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.